ABSCF Recent News AB Science: initiation of a new
Post# of 5
Posted On: 03/01/2014 11:23:40 PM
ABSCF Recent News
AB Science: initiation of a new phase 3 study with masitinib in Prostate Cancer, following encouraging survival results obtained in a phase 2 study GlobeNewswire - Thu Feb 20, 11:09AM CST
AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer GlobeNewswire - Mon Dec 02, 11:32AM CST
AB Science: Masitinib successfully passes futility analysis in pivotal clinical study in Mastocytosis GlobeNewswire - Mon Nov 11, 11:03AM CST
Acceleration of Clinical Program in Amyotrophic Lateral Sclerosis (ALS) Confirms the Proof of Efficacy Data Obtained in Animals GlobeNewswire - Wed Nov 06, 12:26PM CST
AB Science : Financial Results and Key Events of First Half-Year 2013 Marketwire - Fri Aug 30, 12:58PM CDT
AB Science and consortium partners receive EUR8.6m from Epifrance as part of programme for the development of a new therapy in Alzheimer's disease M2 - Tue Jul 23, 5:03PM CDT
AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer's Disease Marketwire - Tue Jul 23, 2:40AM CDT
AB Science Issues 2 Convertible Bonds for a Total Amount of 12.5 M EUR Marketwire - Mon Jun 10, 1:04PM CDT
AB Science: 2012 Annual Financial Results and 2013 First Quarter Revenue Marketwire - Mon Apr 29, 1:17PM CDT
AB Science: initiation of a new phase 3 study with masitinib in Prostate Cancer, following encouraging survival results obtained in a phase 2 study GlobeNewswire - Thu Feb 20, 11:09AM CST
AB Science announces initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer GlobeNewswire - Mon Dec 02, 11:32AM CST
AB Science: Masitinib successfully passes futility analysis in pivotal clinical study in Mastocytosis GlobeNewswire - Mon Nov 11, 11:03AM CST
Acceleration of Clinical Program in Amyotrophic Lateral Sclerosis (ALS) Confirms the Proof of Efficacy Data Obtained in Animals GlobeNewswire - Wed Nov 06, 12:26PM CST
AB Science : Financial Results and Key Events of First Half-Year 2013 Marketwire - Fri Aug 30, 12:58PM CDT
AB Science and consortium partners receive EUR8.6m from Epifrance as part of programme for the development of a new therapy in Alzheimer's disease M2 - Tue Jul 23, 5:03PM CDT
AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer's Disease Marketwire - Tue Jul 23, 2:40AM CDT
AB Science Issues 2 Convertible Bonds for a Total Amount of 12.5 M EUR Marketwire - Mon Jun 10, 1:04PM CDT
AB Science: 2012 Annual Financial Results and 2013 First Quarter Revenue Marketwire - Mon Apr 29, 1:17PM CDT
(0)
(0)AB Science, Paris (ABSCF) Stock Research Links
Scroll down for more posts ▼